Page last updated: 2024-10-18

dalteparin and Bed Sores

dalteparin has been researched along with Bed Sores in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pannucci, CJ1
Wachtman, CF1
Dreszer, G1
Bailey, SH1
Portschy, PR1
Hamill, JB1
Hume, KM1
Hoxworth, RE1
Kalliainen, LK1
Rubin, JP1
Pusic, AL1
Wilkins, EG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Minimization of Bleeding Complications Through Utilization of Perioperative Tranexamic Acid in Breast Surgery: A Randomized Double-blinded Placebo-controlled Trial[NCT02615366]Phase 4800 participants (Anticipated)Interventional2016-02-29Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for dalteparin and Bed Sores

ArticleYear
The effect of postoperative enoxaparin on risk for reoperative hematoma.
    Plastic and reconstructive surgery, 2012, Volume: 129, Issue:1

    Topics: Anticoagulants; Bariatric Surgery; Benchmarking; Clinical Protocols; Enoxaparin; Hematoma; Humans; M

2012